Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses by Kyle T. Reid, Sarah J. Colpitts, Jessica A. Mathews, Abel Santos Carreira, Julia M. Murphy, Dorota T. Borovsky, Sinthuja Jegatheeswaran, Wenhui Cui, Tommy Alfaro Moya, Nadia Sachewsky, James An, Yubing Xia, Arthur Mortha, Jong Bok Lee, Li Zhang, Igor Novitzky-Basso, Jonas Mattsson, Sarah Q. Crome

Get full text